News Wire

Add another regret to my list. A few years ago I interviewed Uwe Reinhardt for this magazine. Our conversation was placed on our website here. It hints, but only hints, at the measure of the man: his brilliance, kindness, humor, and zest for life. After the filming, he and I and the cameraman talked…
High blood pressure should be treated earlier with lifestyle changes and in some patients with medication—at 130/80 mm Hg rather than 140/90—according to the first comprehensive new high blood pressure guidelines in more than a decade. The guidelines are being published by the American Heart Association…
The FDA has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor, Otsuka Pharmaceutical Co., Ltd.) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment…
The FDA has approved aprepitant injectable emulsion (Cinvanti, Heron Therapeutics, Inc.) for intravenous (IV) infusion for treating acute and delayed chemotherapy-induced nausea and vomiting (CINV). The agent, a substance P/neurokinin-1 (NK1) receptor antagonist, is indicated in adults, in combination…
Janssen Biotech, Inc., a unit of health care conglomerate Johnson & Johnson, has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug infliximab (Remicade) produced by South Korea’s Samsung Bioepis Co. Ltd. from being sold in the United States. Janssen, in a document to the…
A new analysis from the CANVAS program has shown that canagliflozin (Invokana, Janssen) demonstrated a reduced risk of cardiovascular (CV) outcomes in patients with and without a history of CV disease. The drug also achieved similar and proportional risk reductions for hospitalization due to heart failure…
Cariprazine (Vraylar, Allergan PLC) has received FDA approval for the maintenance treatment of adults with schizophrenia. Cariprazine was previously approved for adults for the acute treatment of schizophrenia and acute treatment of manic or mixed episodes of bipolar I disorder. "Schizophrenia is one…
Testing of C-reactive protein (CRP) may offer a quick and reliable way to identify the patients most likely to achieve the greatest benefits from long-term treatment with canakinumab (Novartis), according to a new analysis of the phase 3 CANTOS study. The results, presented by Dr. Paul Ridker, MD, at…
The FDA has expanded the indication for dasatinib tablets (Sprycel, Bristol-Myers Squibb Company) to include the treatment of children with Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase. Approval was based on data from 97 pediatric patients with chronic phase CML evaluated…
It’s not easy being an insurance broker these days, as they try to cope with the many challenges involved with the most complicated enrollment season for the ACA since the first enrollment season in 2014. It’s ironic in a way, as Kaiser Health News reports, because Obamacare was meant to be so consumer-friendly…
The FDA has approved brentuximab vedotin (Adcetris, Seattle Genetics, Inc.) for the treatment of adults with primary cutaneous anaplastic large cell lymphoma (pcALCL) or CD30-expressing mycosis fungoides (MF)––the most common subtypes of cutaneous T-cell lymphoma––who have received prior systemic…
Heplisav-B (hepatitis B vaccine, recombinant [adjuvanted], Dynavax Technologies Corporation) has received FDA approval for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. Heplisav-B is the first new hepatitis B vaccine in the United States…
The FDA has approved letermovir (Prevymis, Merck) for the prevention of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT). The medication will be available as once-daily tablets for oral use and as an injection…
More than 600,000 consumers signed up for individual insurance plans under the Patient Protection and Affordable Care Act (PPACA) during the first week of enrollment for 2018, Reuters reports––a positive sign for insurers who take part in the health care program that Republicans are trying to undo.…
Brexanolone (formerly SAGE-547, Sage Therapeutics) helped ease the severity of women’s postpartum depression in two phase 3 clinical trials. Sage has announced positive top-line results from Study 202B in severe postpartum depression (PPD) and Study 202C in moderate PPD. Its proprietary intravenous…

Pages